Inventaire - your friends and communities are your best library - Inventaire

CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease

author

Ester Aso

published in: Frontiers in Neuroscience

date of publication: 2016

language: English

main subject: Alzheimer's disease, CNR2, cannabinoids, cannabinoid receptor

Cites articles 81

Date

Title

Authors

2016-03

Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies
2016-01-05

It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease

Fabio Di Domenico, Eugenio Barone
2016-03-07

Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders

Vincenzo Di Marzo, Fabio Arturo Iannotti
2016-01-01

Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine

Ester Aso, Isidro Ferrer, Margarita Enid Ramírez Carmona, Pol Andrés-Benito
2016-03-11

Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.

Attila Köfalvi, Luis García-García, Cristina Lemos, Miguel A. Pozo, Paula M. Agostinho, Ricardo J. Rodrigues, Rodrigo A. Cunha, María L de Ceballos, Rui O Beleza
2016-02-23

Alzheimer's disease

Giovanni B. Frisoni, Philip Scheltens, Kaj Blennow, Monique Breteler
2015-04-01

Neuroinflammation in Alzheimer's disease

Bente Finsen, Alexei Verkhratsky, Koji Yamanaka, Stéphane Hunot, Olga Garaschuk, Charles A. Dinarello, Guy Brown, Tony Wyss-Coray, Douglas T Golenbock, Richard M Ransohoff, Terrence Town, Sally A Frautschy
2015-12-13

Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus
2015-01-01

Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others

Julian Romero
2015-01-01

Distribution of the Endocannabinoid System in the Central Nervous System

Ken Mackie
2015-01-01

Endocannabinoids and Their Pharmacological Actions

Roger Pertwee
2015-06-18

Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation

Yuchuan Wang, Hayden T Ravert, Robert F Dannals
2015-04-22

Infection, systemic inflammation, and Alzheimer's disease

Siok Lam Lim, Carlos J Rodriguez-Ortiz
2015-01-05

Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission.
2015-01-01

Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice.

Alex Sánchez, Ester Aso
2015-04-01

Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species.

Reinald Pamplona, Aurora Pujol, Ester Aso, Paula Garcia-Esparcia, Manuel Portero-Otin, Isidre Ferrer, Agatha Schluter, Belen Ansoleaga, Margarita Enid Ramírez Carmona
2015-06-15

Endocannabinoids drive the acquisition of an alternative phenotype in microglia.

Silvia Ortega-Gutiérrez, Ana Feliú, Francisco Carrillo-Salinas
2014-11-29

Targeting microglia for the treatment of Alzheimer's disease
2014-01-01

The potential therapeutic effects of THC on Alzheimer's disease

Neel R Nabar
2014-07-01

Innate immune activation in neurodegenerative disease
2014-05-10

Early detection of Alzheimer's disease using PiB and FDG PET

William E. Klunk
2014-03-14

CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease

Valérie Vingtdeux, Philippe Marambaud
2014-03-05

Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic

Ester Aso, Isidro Ferrer
2014-03-01

The influence of cannabinoids on generic traits of neurodegeneration
2014-12-20

Enhanced microglial activity in FAAH(-/-) animals

Onder Albayram, Bruno Pradier
2014-09-28

Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model

Onder Albayram, Joachim Schultze
2013-01-31

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

Eicke Latz, Douglas T Golenbock
2013-09-05

Self-propagation of pathogenic protein aggregates in neurodegenerative diseases

Mathias Jucker
2013-11-01

Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling

Zhao-Qian Teng
2013-09-13

Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro

Jesper L Maag
2013-08-09

Cannabinoid receptor CB2 modulates axon guidance

Maurice Ptito
2013-03-18

Transport of endocannabinoids across the plasma membrane and within the cell

Article - wd:Q26746050

Welcome to Inventaire

the library of your friends and communities

you are offline